Danish Pharma ALK pays ARS $145m for Neffy nasal spray licensing deal
HQ Team November 13, 2024: ALK-Abelló, the Danish pharma company has acquired exclusive rights to Neffy (epinephrine nasal spray) from ARS Pharmaceuticals for.
Pharma
Drugs
Health
Medical
Harvard develops drug-free nasal spray to block viruses, bacteria
Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.
Drugs
Medical
Pharma
US drug regulator approves first nasal spray to prevent influenza
HQ Team September 22, 2024: AstraZeneca’s Flumist, the first at-home flu vaccine, got approved by the Food and Drug Administration, enabling consumers with.
Drugs
Health
Pharma
US-based ARS’s nasal spray to treat allergic reactions gets FDA nod
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.
Drugs
Pharma
Finnish researchers say new COVID-19 nasal spray hold future promise
A nasal spray developed by Finnish researchers can prevent COVID-19 disease caused by all known variants and stop the transmission of the virus, according to.
Drugs
Pharma
Merck’s Covid-19 pill fails initial trial; AstraZenaca’s nasal spray too ineffective
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial